Antiulcer Drugs
Antiulcer drugs are medications used to treat gastric and duodenal ulcers, gastritis, and acid-related disorders by reducing acid production, neutralizing acid, protecting the mucosal lining, or eradicating Helicobacter pylori infection.
Classification
- 1. Proton pump inhibitors (PPIs): Omeprazole, Pantoprazole, Lansoprazole
- 2. H2 receptor antagonists: Cimetidine, Famotidine
- 3. Antacids: Aluminium hydroxide, Calcium carbonate, Magnesium hydroxide
- 4. Mucosal protective agents: Bismuth subsalicylate
- 5. Antibiotics (for H. pylori eradication): Amoxicillin, Clarithromycin, Tetracycline
Pharmacodynamics
- PPIs irreversibly inhibit the H+/K+ ATPase enzyme in gastric parietal cells, reducing basal and stimulated acid secretion.
- H2 receptor antagonists block histamine H2 receptors on gastric parietal cells, decreasing cAMP-mediated acid secretion.
- Antacids neutralize existing stomach acid by forming salts and water, increasing gastric pH and providing rapid symptomatic relief.
- Mucosal protective agents (e.g. bismuth subsalicylate) coat ulcers and inflamed mucosa, forming a barrier against acid and pepsin. Bismuth also has antimicrobial action against H. pylori.
- Antibiotics eliminate H. pylori, the key causative agent of chronic gastritis and peptic ulcers, by targeting bacterial DNA, protein, or cell wall synthesis.